"Remind-to-move" for Promoting Upper Extremity Recovery in Patients With Stroke After Subacute Discharge
Stroke, Upper Extremity Hemiplegia
About this trial
This is an interventional treatment trial for Stroke
Eligibility Criteria
Inclusion Criteria:
- Frst-time ischemic or hemorrhagic stroke confirmed by magnetic resonance imaging or X-ray computed tomography
- Unilateral hemispherical involvement
- Aged 18 or above
- Time since onset less than 6 months
- Functional Test for Hemiplegic Upper Extremity Hong Kong version (FTHUE-HK) ≥ 3 (maximum 7)
- Able to understand verbal instruction and follow one-step commands
- Modified Ashworth Scale (MAS) ≤ 2
- Mini-mental State Examination (MMSE) ≥ 19
- No complaint of excessive pain or swelling over hemiplegic arm
- Sensation on the affected wrist intact or with mild impairment only (National Institute of Health Stroke Scale=0 or 1).
Exclusion Criteria:
- Participating in any experimental or drug study
- Unable to give consent to participate
- Of inadequate balance as indicated by the inability to stand for at least 2 minutes with or without arm support
- Having history of botulinum toxin injection in 3 months.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Sham Comparator
Other
Experimental
Sham treatment
Control
Participants receive "Remind-to-move" by means of vibration emitted through sensory cueing wristwatch devices, 3 consecutive hours daily, for 4 weeks, as well as usual care during the intervention period.They are also encouraged to use their arms as much as possible and the accelerometer built-in the device record the arm movement during daily activities.
Participants wear sham wristwatch devices but without vibration cueing, 3 consecutive hours daily, for 4 weeks, as well as usual care during the intervention period. They are also encouraged to use their arms as much as possible and the accelerometer built-in the device record the arm movement during daily activities.
Participants receive usual care only during the intervention period.